Four life-sciences audiences, mapped properly.
Each sub-sector buys differently, with a different committee and a different evidence standard. Coverage, personas and campaign design are built per sector rather than reused.
Pharma & biopharma accounts mapped
Emerging & mid-size biotechs profiled
MedTech organisations in active coverage
Global CROs tracked end-to-end
Specific scientific areas, not a generic pharma list.
We work to cover each relevant contact across every account on the database, down to bespoke functions and titles.
Organisation types
- CROs
- CDMOs and CMOs
- Emerging biotechs
- Established biotechs
- Pharma and biopharma
- Medical devices and diagnostics
Functions and titles
- Lab
- Scientific
- Analytical
- Corporate
- R&D
- Quality
- Clinical
- Regulatory
- Drug discovery
- Bespoke functions and titles
Coverage areas
- Small biopharma
- Biopharma other
- Pharma
- Analytical science
- Environmental science
- Food and beverage labs
- Material science
Key growth markets
- Sepsis
- Cell and gene therapy
- Mass spec
- PFAS
- Bioprocessing
- Cancer research and oncology
- AI and automation
30+ years experience in this sector
Life sciences is where this business started, and it is still the practice we know best.
Publisher and event campaign experience
Campaigns delivered for scientific publishers and event companies across life sciences.
Every contact, every account
We work to cover each relevant contact across every account on the database, not one name per company.
Pharma & Biopharma
Large and mid-size pharmaceutical and biopharmaceutical companies, mapped by therapeutic area, pipeline focus and region across the US, Europe and APAC.
Typical campaigns
- Content syndication into named enterprise accounts
- Multi-touch email activation across large buying groups
- Executive roundtable audience acquisition
Personas we reach
- Clinical operations and clinical development
- Medical affairs
- Regulatory affairs
- Pharmacovigilance & QA
- Commercial and market access
- C-suite and functional heads
Emerging & mid-size Biotech
Emerging and mid-size biotechs segmented by modality and therapeutic focus - small molecule, biologics, cell and gene therapy - and by company stage from pre-clinical through commercial.
Typical campaigns
- Stage-segmented email activation
- Bespoke content hubs for funded and scaling accounts
Personas we reach
- Founders and C-suite
- Heads of clinical operations
- CMC and manufacturing leads
- Regulatory and quality
- Business development
CRO & CDMO
Global and regional contract research, development and manufacturing organisations, tracked across service lines, therapeutic capability and geography.
Typical campaigns
- Partner and sponsor-side account targeting
- Content syndication around capability and capacity content
- Webinar and congress audience acquisition
Personas we reach
- Business development and commercial leadership
- Operations and delivery leadership
- Scientific and technical directors
- Quality and regulatory
MedTech
Device, diagnostics and medical technology organisations, segmented by product category, regulatory class exposure and region.
Typical campaigns
- Product-launch demand generation
- Bespoke target account lists across hospital and health-system suppliers
- Nurture and SDR support on long device sales cycles
Personas we reach
- R&D and product development
- Regulatory affairs and quality
- Clinical affairs
- Commercial and channel leadership
Your ICP doesn't fit neatly into one of these?
Most don't. We build the account universe to your definition, not to a fixed sector taxonomy.
Start with a scoped pilot.
Tell us the accounts you want to reach and the lead criteria you work to. We'll come back with a scoped pilot within one working day.
Start a pilot